603 page 1/2 15 July 2018 Form 603 Corporations Act 2001 Section 671B Notice of initial substantial holder To Company/registered scheme/notified foreign Argent BioPharma Ltd passport fund name ACN/ARSN/APFRN NFPFRN (if applicable) ACN 116 800 269 1. Details of substantial holder (1) Name Oak...
Becoming a substantial holder
Filed with ASX · · 3 pages · English
Release
Earlier from Argent Biopharma
- RGT Executes Global Licence for Non-Core Cannabis Genetics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
- Date of AGM and Closing Date for Director Nominations
- Strategic Focus on Immune Modulation and Longevity
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma